[ad_1]
Researcher Tran Vi (Chen Wei) speaks on China Central Television – Photo: CCTV
Newspaper South China Morning Mail (SCMP) On February 27, it was reported that Ms. Chen Wei (Chen Wei), China’s top military scientist, had just revealed that Chinese research groups had begun studying vaccines against variants of the SARS-CoV-2 that cause COVID. ” long-standing “. -19.
“We are tracking and analyzing a global database of COVID-19 patients, with more than 400,000 samples through genetics and biology. Then our labs cross-examine the antimicrobial response of virus variants, such as Brazilian strains. Current, South African and British vaccines “- said Ms Tran Vi in an interview with China Central Television (CCTV) on February 27.
Ms. Tran Vi is a member of the China Civil Engineering Institute (CAE) and is currently a researcher at the Military Medical Research Institute of the People’s Liberation Army (PLA) Academy of Military Sciences.
“Research has started a long time ago to find new and more powerful vaccines targeting variations,” said the scientist that China wants to be prepared to deal with any situation that may occur.
“Vaccines targeting variants of the virus may not be used, but we have to prepare them,” explained Ms Tran Vi.
According to the newspaper SCMPChina has approved four domestically developed vaccines for wide use by the public. However, they still have to “green light” for any foreign vaccines.
During the week, China announced the launch of its first single-dose vaccine, called Ad5-nCoV. Leaf Global times states that phase 1 clinical trials with this vaccine began on March 16, 2020, marking it as “the world’s first COVID-19 candidate vaccine to enter clinical screening.”
Many other countries and companies are also working on vaccines that address variants of the SARS-CoV-2 virus. Moderna (USA) recently said that it had developed a version of the vaccine to fight the virus in South Africa and sent the results to the National Institutes of Health for evaluation.
